NCT05043142 - Epidemiological Study of the COVID-2019 in Participating Organizations. | Biotech Hunter

Enrollment

3,632

Participants

Timeline

Start Date

March 16, 2021

Primary Completion Date

June 23, 2021

Study Completion Date

June 23, 2021

Conditions

Covid19

Interventions

DIAGNOSTIC_TEST

ELISA test for the antibodies to COVID-2019.

Each subject will be assigned an individual number, which will be used for conduction of a rapid ELISA test for the antibodies to COVID-2019. Subjects will be notified of the test results.

Trial Locations (7)

65000

InterChem SLC, Odesa

03038

SI National Institute of Phthisiology and Pulmonology named after F.G. Yanovsky, Kyiv

03151

Institute Hyalual LLC, Kyiv

Yuria-Pharm LLC, Kyiv

03680

Medical Center M.T.K. LLC, Kyiv

04073

Infuzia PJSC, Kyiv

04215

Diatom LLC, Kyiv